| pubmed-article:15694949 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0023676 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0741968 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0082608 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C1280412 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0455825 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C1554963 | lld:lifeskim |
| pubmed-article:15694949 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:15694949 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15694949 | pubmed:dateCreated | 2005-2-7 | lld:pubmed |
| pubmed-article:15694949 | pubmed:abstractText | The Hypertension High Risk Management trial (HYRIM) investigated the effect of fluvastatin treatment and lifestyle intervention on development of carotid intima-media thickness (IMT) in drug-treated hypertensive patients. | lld:pubmed |
| pubmed-article:15694949 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15694949 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15694949 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15694949 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15694949 | pubmed:issn | 0021-9150 | lld:pubmed |
| pubmed-article:15694949 | pubmed:author | pubmed-author:HjermannIngva... | lld:pubmed |
| pubmed-article:15694949 | pubmed:author | pubmed-author:HolmeIngarI | lld:pubmed |
| pubmed-article:15694949 | pubmed:author | pubmed-author:AnderssenSigm... | lld:pubmed |
| pubmed-article:15694949 | pubmed:author | pubmed-author:HjelstuenAnne... | lld:pubmed |
| pubmed-article:15694949 | pubmed:author | pubmed-author:BjerkanKirsti... | lld:pubmed |
| pubmed-article:15694949 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15694949 | pubmed:volume | 178 | lld:pubmed |
| pubmed-article:15694949 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15694949 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15694949 | pubmed:pagination | 387-97 | lld:pubmed |
| pubmed-article:15694949 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:meshHeading | pubmed-meshheading:15694949... | lld:pubmed |
| pubmed-article:15694949 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15694949 | pubmed:articleTitle | Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. | lld:pubmed |
| pubmed-article:15694949 | pubmed:affiliation | Center for Preventive Medicine, Ullevål University Hospital, 0407 Oslo, Norway. sigmund.anderssen.nih.no | lld:pubmed |
| pubmed-article:15694949 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15694949 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15694949 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15694949 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15694949 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15694949 | lld:pubmed |
